Samsrita Labs Share Price Today

Samsrita Labs Q2FY27 Results: Zero revenue, net loss narrows to ₹11.61 lakh

Standalone net loss narrowed to ₹11.61 lakh in Q2FY27 from ₹493.50 lakh in Q2FY26. Revenue from operations remained zero for both the quarter and half-year periods. Consolidated net loss widened to ₹31.63 lakh due to share of losses in associates. Cash and cash equivalents decreased to ₹100.29 lakh from ₹162.88 lakh in H1FY27. Board approved ₹1 crore investment in S Labs Hygiene Care Private Limited via CCPS.

Samsrita Labs shareholders approve material related party transactions

Shareholders approved three ordinary resolutions for material related party transactions. 99.27% of votes polled were in favor across all three resolutions. Promoters abstained from voting due to interested party status. Only 24.91% of eligible public shares participated in the voting process.

Samsrita Labs schedules EGM on Oct 26 to approve ₹26 crore RPTs

Samsrita Labs schedules EGM for October 26, 2026, to approve material RPTs. Proposed sales of goods to S Labs Hygiene Care capped at ₹25 crore. Investment of up to ₹1 crore in CCPS of S Labs Hygiene Care approved. Unsecured loan of ₹1 crore at 9% interest from director also tabled. Transaction values are exceptionally high compared to FY26 turnover of ₹1.81 lakh.

Samsrita Labs Q1 Results: Standalone loss widens to ₹31.47 lakh

Samsrita Labs Ltd posted a Q1FY27 standalone loss of ₹31.47 lakh, up from ₹11.87 lakh in Q4FY26, as other expenses rose sharply without any revenue support. Consolidated losses narrowed to ₹18.87 lakh due to a ₹12.60 lakh profit contribution from associate companies, offsetting the parent's operational drag.

Samsrita Labs AGM scheduled for Aug 10, 2026

Samsrita Labs Limited has scheduled its 30th Annual General Meeting for the financial year 2026-27 on August 10, 2026, via video conferencing. Remote e-voting commences on July 24, 2026, and concludes on August 22, 2026, with a cut-off date of August 3, 2026.

Samsrita Labs appoints Varanasi as independent director

Samsrita Labs Limited has appointed Mr. Satyanarayana Murthy Varanasi as an Additional Director in the Independent category for a five-year term, effective July 4, 2026. The board also approved a scheme to reduce the issued, subscribed, and paid-up share capital by ₹11.37 crore to set off accumulated losses, involving the cancellation of 11,37,48,550 equity shares. Additionally, the board appointed Mr. Ravi Kanth Naga Pattabhi Chopperla as an Additional Director and approved the alteration of the Main Object Clause to include pet animal healthcare and wellness businesses. The Annual General Meeting for FY26 is set for August 10, 2026.